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Conclusion: More males were presented with premarital,
extramarital sex and multiple sex partners and females
were more vulnerable. Health seeking behavior of females
was affected by male dominance and their economic
dependency on others.
PP-061 Clinical study of patients with hand, foot,
and mouth disease associated with aseptic
meningitis and encephalitis
X.F. Duan*, B. Li, H.H. Zeng, L.H. Wang, C. Qian, F.X. Chen,
L. Pang, X.W. Li, Z.H. Chen. Department of Infectious
Diseases, Beijing Ditan Hospital, Beijing, 100015, China
Background: In Beijing, from May to August, 2008, an
epidemic of hand, foot, and mouth disease (HFMD) occurred
with central nervous system (CNS) complications. METHODS:
Clinical data of 91 inpatients who suffered from HFMD
associated with aseptic meningitis and 54 HFMD cases
associated with encephalitis were retrospectively analyzed,
and were compared with 151 HFMD children without CNS
complications.
Results: 91 cases with a mean age of 44.5±32.6 months,
had associated aseptic meningitis, and all survived.
The most frequently associated symptoms were vomiting
(84.6%), myoclonic jerks (60.4%), neck stiffness (54.9%)
and headache (47.3%). 54 children with encephalitis
(mean age 19.8±13.0 months) had symptoms of altered
consciousness (68.6%), myoclonic jerks (77.2%), convulsions
(27.8%), and cranial nerve involvement (18.5%). 3 cases
died of neurogenic pulmonary edema. Among 54 children,
15 patients (27.8%) had associated acute ﬂaccid paralysis
(AFP). The MRI of 7 cases displayed myelitis, and 3 cases
displayed brainstem encephalitis. 7 of 15 children still had
neurologic deﬁcits when they were discharged. There was a
very signiﬁcant difference in age of onset between children
with aseptic meningitis and those associated encephalitis
(P< 0.01). Most of abnormal neurologic ﬁndings except
AFP occurred from days 2 to 4 of the clinical course.
All 151 children without CNS complications recovered.
Compared with non CNS involved HFMD patients, fever in
the CNS complications group was longer (P< 0.01) and higher
(P< 0.05), and hyperglycaemia and leucocytosis were more
common (P< 0.01) (Table 1).
Table 1: Clinical feature of aseptic meningitis and encephalitis
Number of cases Aseptic meningitis group Encephalitis group
Total cases 91 54
Vomiting 77 (84.6%) 6 (11.1%)
Myoclonic jerks 55 (60.4%) 39 (77.2%)
Neck stiffness 50 (54.9%) 0
Headache 43 (47.3%) 3 (5.6%)
Altered consciousness 0 37 (68.6%)
Convulsions 0 15 (27.8%)
Cranial nerve involvement 0 10 (18.5%)
Acute ﬂaccid paralysis 0 15 (27.8%)
Death 0 3 (5.6%)
PP-062 Eliminating risk of transferring infection with
mouth-to-mouth breathing in CPR, with a new
technique for CPR
M. Zandi1 *, S.M. Alavian2. 1Tarbiat Modares University,
Tehran, Iran, 2Baqiyatallah University of Medical Sciences,
Baqiyatallah Research Center for Gastroenterology & Liver
Disease (BRCGL), Tehran, Iran
Introduction: A biomedical engineer at Purdue University
has developed a new method to perform cardiopulmonary
resuscitation that promises to be more effective than
standard CPR and eliminates risk of transferring infections
with mouth-to-mouth resuscitation. Geddes has developed
the ﬁrst new CPR alternative, called “only rhythmic
abdominal compression”, or OAC-CPR, which works by
pushing on the abdomen instead of the chest.
Content: Conventional CPR has a success rate of 5 percent
to 10 percent, depending on how fast rescuers are able
to respond and how well the procedure is performed. In
standard chest-compression CPR, which has been in practice
since the 1960s, the rescuer pushes on the chest and
blows into the subject’s mouth twice for every 30 chest
compressions. However, the risk of infection is so grave that
many doctors and nurses often refuse to administer mouth-
to-mouth resuscitation. In one 1993 study of 433 doctors
and 152 nurses, 45 percent of doctors and 80 percent of
nurses said they would refuse to administer mouth-to-mouth
resuscitation on a stranger. In OAC-CPR, no rescue breaths
are needed, an important factor because it eliminates risk of
transferring infections with mouth-to-mouth resuscitation.
Although the American Heart Association (AHA) has available
small packets containing a mouth guard, the average person
in a park who attempts CPR on a stranger likely does not
have one immediately available. Another beneﬁt of OAC-
CPR is that it eliminates rib fractures, which are commonly
caused by compressing the chest if you push too hard,
but if you don’t push hard you won’t save the person.
It requires only one rescuer. Instead of two breaths for
every 30 chest compressions, the new procedure provides
a breath for every abdominal compression because pushing
on the abdomen depresses the diaphragm toward the head,
expelling air from the lungs. The release of force causes
inhalation. If you pushed on the abdomen after each
chest compression you could double the CPR blood ﬂow.
The procedure provides a new way to effectively perform
“coronary perfusion”.
Conclusion: Whether the procedure gains widespread
acceptance depends on whether other researchers can
reproduce the results.
PP-063 The Research of signal transduction mechanism
in Ana-1 Cells infected by Inﬂuenza Virus (FM1)
and the Intervention of Dureping Injection
L.G. Gu, Y.L. Zhang, X.Y. Niu*, S. Jing, Y. Zhou, F. Wang,
C.J. Zhang. The Key Laboratory of Education Ministry
in Anti-Virus by TCM in Beijing University of Chinese
Medicine, Beijing 100029, China
Objective: Observe the effect of Heat-clearing and
Detoxicating Herb Dureping injection (DRP) on key proteins
and cytokines of TLR7 signal passageway in Ana-1 cells
infected by Inﬂuenza Virus (FM1). Study the Signal
Transduction Mechanism in Ana-1 Cells induced by FM1and
the Intervention of Dureping Injection.
Method: Group four cell control group, FM1 infected group,
DRP1mg/ml group and DRP 10mg/ml group. After giving DRP
12 h and 24 h, detect the mRNA transcriptional level of
TLR7, MyD88, TRAF-6, IRAK-4 and NF-úB p65 by Real-Time
PCR; the protein level of NF-úB p65 by Western-Blot; the
content of these cytokines: RANTES, MIP-1a, IP-10, IL-6 and
IFN-b by ELISA in different groups.
Results: The mRNA transcriptional level of TLR7, MyD88,
TRAF-6, IRAK-4 and NF-úB p65 in Ana-1 cells infected by
FM1 is apparently down regulated by DRP (p < 0.01).The
protein expression of NF-úB p65 of Ana-1 cells infected by
FM1 is also apparently down regulated by DRP (p < 0.01).
The protein level of cytokines: RANTES, MIP-1a, IP-10, IL-6
of Ana-1 cells infected by FM1 is apparently down regulated
by DRP (p < 0.01).But the protein level of cytokine IFN-b of
Ana-1 cells infected by FM1 is apparently up regulated by
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DRP (p < 0.05). All those regulations are dose dependent and
time dependent.
Conclusions: The FM1 induce the TLR7 signal Transduction
passageway and serial reactions in it. One of the Mechanism
of DRP curing the Inﬂuenza Virus FM1 is effecting on NF-úB
through inhibiting MyD88 in order to regulate the target
gene expression downstream in that signal passageway.
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PP-064 Reactivation of herpes viruses in the central
[CNS] and peripheral nervous systems [PNS]:
One hundred years from Ramsay Hunt clinical
description to PCR veriﬁcation
S. Bogger Goren*. Zamenhoff Medical Center, Tel Aviv,
Israel
The clinical spectrum of chronic or recurrent manifestations
of CNS and PNS diseases suspected to be related to the
group of Herpes Viruses has been expanded considerably
during the last hundred years since J. Ramsay Hunt ﬁrst
deﬁned in 1907 a syndrome of Zoster Oticus accompanied
by peripheral facial nerve paralysis which bears his name,
Ramsay Hunt Syndrome [RHS], and suggested its association
with Varicella zoster virus reactivation.
In this paper the long term [up to 30 years] clinical evolution
of severe, incapacitating attacks of a complex of neurologic
symptoms in two adult women will be presented together
with its diagnostic dilemmas.
These patients were seen by various specialists and
were subjected to numerous diagnostic procedures to
investigate and verify various presumptive non infectious
CNS, orthopedic or ENT disorders. Variable therapeutic
approaches have failed to alleviate their symptoms. Invasive
therapeutic procedures offered to the patients were refused
by them.
Based on meticulous clinical history and physical
examination, the possibility of recurrent reactivations
of VZV in these patients was contemplated (bearing in
mind the less frequent presentations of RHS), and the
patients were put on full dose courses of Acyclovir (Zovirax
or Valtrex). A dramatic and almost immediate clinical
subjective relief and obvious disappearance of symptoms
ensued. Maintenance on a daily-based low dose Acyclovir for
the following months prevented any further exacerbations
and the patients regain full activity and quality of life.
The contribution of new virological diagnostic techniques
in general, and PCR, in particular, to the identiﬁcation and
understanding of variable chronic and recurrent CNS and
PNS diseases and disorders in general, and VZV involvement
in particular, is discussed.
PP-065 Survey of the seroprevalence of CMV among
hemodialysis patients in Urmia, Iran
Z. Rostam, Z.R. Khameneh*, N. Sepehrvand, F. Eslamlu.
Urmia University Medical Science, Iran
Background and Aim: Cytomegalovirus (CMV) causes
infection in immunocompromised, transplant recipients
and those who receive blood transfusion frequently. Risk
factors for primary CMV infection are blood transfusion
(including clotting factors, etc), recipients of infected
transplants, hemodialysis and the frequency of dialysis in
a week. This study aimed to determine the prevalence of
cytomegalovirus (CMV) antibodies in end-stage renal disease
(ESRD) patients which undergo hemodialysis.
Material and Methods: This study has a cross-sectional
design, which is executed in 2007 among hemodialysis
patients in Urmia, Iran. Sera of 84 Hemodialysis patients
have been investigated by CMV-speciﬁc immunoglobulin G
(IgG) using a CMV IgG enzyme-labeled antigen test.
Collected data were analyzed by descriptive statistics and
chi-square test via SPSS software ver11.5.
Results: In our study, 84 patients who regularly underwent
hemodialysis were studied. Forty-four patients were male
and 40 female with the range 23 82 years age. In the
time of evaluation, 65 patients (77.4%) were anti-CMV IgG
positive and 6 (7.1%) were anti-CMV IgM positive. There
was no relationship between the antibody titer and dialysis
duration, or frequency of HD in a week.
Conclusion: We recommend that every patient who has
undergone hemodialysis received blood products free of
CMV. Development of a vaccine against cytomegalovirus is
essential and could be very life & cost-saving.
PP-066 Survey of the seroprovalence of HTLV I/II in
hemodialysis patients and blood donors in
Urmia
Z. Rostam, Z.R. Khameneh*, M. Baradaran, N. Sepehrvand.
Urmia University Medical Science, Iran
Introduction: HTLV is a virus from retroviridae family.
It is a cause of Lukemia/Lymphoma disease in adults,
Tropical spastic paralysis, HTLV associated myelopathy,
spastic paraparesis, (HAM/TSP) and some nervous system
disease and etc. It is transmitted by means of blood products
via blood transfusion to recipients.
Material and Methods: This study has a cross-sectional
design, which is executed from April of 2005 until
January of 2006 among healthy blood donors and in 2006
among hemodialysis patients in Urmia, Iran. The serum of
2046 blood donors and 95 Hemodialysis patients has been
investigated by enzyme-linked immunosorbent assay (ELISA)
for anti HTLV-I/II and positive cases has been conﬁrmed by
western blot.
Results: There were 1910 male persons (93.4%) among
2046 donors, and 136 cases (6.6%) were female. Serum
of 1997 cases (97.6%) was negative, and 49 cases (2.6%)
were positive as a result of ELISA tests. Positive cases were
investigated by western blot and 37 cases (75.5%) were
negative, 5 persons (10.2%) were IND and 7 persons (14.3%)
were HTLV positive. Among these seven persons, there are
6 cases (85.6%) with HTLV-I, and only one person (14.3%)
with HTLV-I/II infection. Total serologic prevalence of HTLV
in healthy blood donors is 0.34%.
Conclusion: Observation of such a high serologic prevalence
in the population of blood donors in Urmia city,
suggesting the high probability of transmission through blood
transfusion, and so screening of blood donors for human
T-lymphocyte virus is essential and has suggested.
PP-067 Blood safety and prevalence of transfusion
transmissible viral infections among donors at
the Red Cross Blood Bank in Gondar
E. Diro1 *, S. Alemu1, A.G. Yohannes2. 1Department of
Internal Medicine, Gondar University, 2Department of
HIV/AIDS, Alert Hospital, Ethiopia
Background: Even though millions of lives are saved by
blood transfusion, unsafe transfusion is also putting millions
of people at risk of Transfusion Transmissible Infections
(TTI).
Objective: To measure the magnitude of TTIs and related
risk factors among blood donors.
Setting: Ethiopian Red Cross Blood Bank at the Gondar
University Hospital in Northwest Ethiopia.
Methods: Cross-sectional study among volunteer blood
donors at the Red Cross Blood Bank in Gondar University
Hospital.
Results: Consecutive 600 adult voluntary donors from April
to July 2004 were included. Their mean age was 28± 10.4
years, and 66% were urban dwellers. Donors were farmers
